Breaking News Instant updates and real-time market news.

FSB

Franklin Financial Network

$35.50

-0.05 (-0.14%)

16:19
10/18/16
10/18
16:19
10/18/16
16:19

Franklin Financial Network reports Q3 EPS 62c, consensus 66c

Reports Q3 provision for loan losses $1.392M and net charge-offs of 0.01% of average loans compared with negligible net recoveries for the Q2.

  • 19

    Oct

FSB Franklin Financial Network
$35.50

-0.05 (-0.14%)

06/29/16
BOFA
06/29/16
DOWNGRADE
Target $35
BOFA
Neutral
Franklin Financial Network downgraded to Neutral from Buy at BofA/Merrill
BofA/Merrill downgraded Franklin Financial to Neutral and lowering its price target to $35. The firm adjusted earnings estimates for the pushed out timeline of the Civic bank merger and a lower interest rate outlook, and expects shares to consolidate the significant gains since the company's 2015 IPO.
06/29/16
06/29/16
DOWNGRADE

On The Fly: Top five analyst downgrades
Catch up on the today's top five analyst downgrades with this list compiled by The Fly: 1. HeartWare (HTWR) downgraded to Equal Weight from Overweight at Barclays by analyst Matthew Taylor, saying he does not expect a competing takeover bid to Medtronic's (MDT) offer. The analyst raised his price target for the shares to $58 from $35. Similarly, shares were downgraded to Market Perform from Outperform at Wells Fargo, with analyst Larry Biegelsen saying he sees a low likelihood that a higher bidder will emerge. The analyst believes Medtronic paid a fair valuation for HeartWare. HeartWare was also downgraded to Neutral from Buy at BTIG. 2. Esperion (ESPR) downgraded to Neutral from Overweight at JPMorgan by analyst Jessica Fye, who slashed her price target for shares to $15 from $50. The analyst says last night's regulatory update is a net negative. Disappointingly, the FDA did not sign off on the use of LDL-C lowering as an acceptable regulatory endpoint for approval of bempedoic acid for the treatment of statin-intolerant patients, Fye tells investors in a research note. The analyst still believes bempedoic acid is an effective LDL-C lowering agent, but now sees a drawn out path to approval in the U.S. Esperion was also downgraded to Underperform at Neutral at Credit Suisse by analyst Vamil Divan, who says the update on the development plans for bempedoic acid leaves him increasingly concerned about the products outlook in the U.S. market. The analyst was surprised that the FDA may not be willing to allow LDL-C as a surrogate endpoint for initial approval but believes there will be significant pressure, and limited upside, on shares until that certainty is obtained, and that process may take years to play out. Esperion was also downgraded to Sector Perform from Outperform at RBC Capital. 3. Comerica (CMA) downgraded to Underperform from Neutral at BofA/Merrill, which reduced its price target to $36 from $45. The firm's analyst lowered estimates 8% below consensus for 2016 and 17% below consensus in 2017 due to low rates that will pressure spread revenue growth, slower U.S. economic growth, and continued reserve build. The firm also downgraded Regions Financial (RF), Synovus (SNV), Texas Capital (TCBI) and Franklin Financial Network (FSB) to Neutral from Buy, as well as Zions Bancorp (ZION) to Underperform from Neutral. 4. comScore (SCOR) downgraded to Neutral from Positive at Susquehanna, citing uncertainty surrounding its accounting issues. The firm continues to like the long-term fundamental story, but with an unclear timeline for its resolution, they are moving to the sidelines. Susquehanna lowered its price target to $18 from $30 on comScore shares. 5. Harman (HAR) downgraded to Sector Perform from Outperform at RBC Capital partly based on the low number of new car launches next year, the firm's forecast for reduced production by the company's European customers, and the firm's reduction in its U.S. auto production versus its previous forecast. Additionally, the firm expects GM (GM) to delay a number of its connected car launches that had been slated for fiscal 2017 until fiscal 2018. The firm lowered its price target to $73 from $85. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
09/06/16
RAJA
09/06/16
INITIATION
Target $40
RAJA
Outperform
Franklin Financial Network initiated with an Outperform at Raymond James
Raymond James analyst Daniel Cardenas initiated Franklin Financial with an Outperform and $40 price target. The analyst said the company remains well positioned to continue to post double digit balance sheet and income statement growth, supported by a sound capital base and shareholder-oriented management team. He believes these factors leave the company well-positioned to experience a pickup in earnings power, tangible common equity levels, and tangible book value per share.

TODAY'S FREE FLY STORIES

RNVA

Rennova Health

$0.22

0.0086 (4.07%)

, CI

Cigna

09:35
09/25/17
09/25
09:35
09/25/17
09:35
Hot Stocks
Rennova Health announces appeals court win for Cigna suit »

Rennova Health (RNVA)…

RNVA

Rennova Health

$0.22

0.0086 (4.07%)

CI

Cigna

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DDAIF

Daimler AG

$79.70

0.09 (0.11%)

09:31
09/25/17
09/25
09:31
09/25/17
09:31
Hot Stocks
Daimler Trucks tests truck platooning on public highways in the U.S. »

As the first commercial…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

WPZ

Williams Partners

09:30
09/25/17
09/25
09:30
09/25/17
09:30
Initiation
Williams Partners initiated  »

Williams Partners…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

WMB

Williams

09:30
09/25/17
09/25
09:30
09/25/17
09:30
Initiation
Williams initiated  »

Williams initiated with…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

YUM

Yum! Brands

09:30
09/25/17
09/25
09:30
09/25/17
09:30
Recommendations
Yum! Brands analyst commentary  »

Yum! Brands' Taco…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Sep

  • 28

    Sep

ICPT

Intercept

$61.59

-12.11 (-16.43%)

09:30
09/25/17
09/25
09:30
09/25/17
09:30
Hot Stocks
Intercept says talks with FDA 'evolving' »

When asked on…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

SMMF

Summit Financial Group

$25.01

0.22 (0.89%)

09:30
09/25/17
09/25
09:30
09/25/17
09:30
Downgrade
Summit Financial Group rating change  »

Summit Financial Group…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PCMI

PCM, Inc.

$13.20

0.2 (1.54%)

09:29
09/25/17
09/25
09:29
09/25/17
09:29
Hot Stocks
PCM, Inc. acquires Stack Technology, subsidiaries »

PCM, Inc. has acquired…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Sep

BIIB

Biogen

$318.46

3.43 (1.09%)

, NVO

Novo Nordisk

09:28
09/25/17
09/25
09:28
09/25/17
09:28
Hot Stocks
Biogen apponts Camille Lee as SVP, Alzheimer's Disease Therapeutic Area »

Biogen (BIIB) announced…

BIIB

Biogen

$318.46

3.43 (1.09%)

NVO

Novo Nordisk

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

09:27
09/25/17
09/25
09:27
09/25/17
09:27
Conference/Events
Wells Fargo financial team holds an analyst/industry conference call »

Wells Fargo Financial…

EXEL

Exelixis

$24.47

-3.54 (-12.64%)

, PTN

Palatin

09:24
09/25/17
09/25
09:24
09/25/17
09:24
Hot Stocks
On The Fly: Pre-market Movers »

HIGHER: Exelixis (EXEL),…

EXEL

Exelixis

$24.47

-3.54 (-12.64%)

PTN

Palatin

AGN

Allergan

ICPT

Intercept

$61.59

-12.11 (-16.43%)

GPC

Genuine Parts

TGT

Target

LLY

Eli Lilly

AAPL

Apple

$151.89

-1.5 (-0.98%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

  • 25

    Sep

  • 25

    Sep

  • 25

    Sep

  • 25

    Sep

  • 26

    Sep

  • 27

    Sep

  • 18

    Oct

  • 19

    Oct

  • 22

    Oct

  • 30

    Oct

TSLA

Tesla

$351.09

-15.39 (-4.20%)

, GM

General Motors

09:24
09/25/17
09/25
09:24
09/25/17
09:24
Periodicals
China may ease foreign automaker rules aiding Tesla, WSJ reports »

China officials may ease…

TSLA

Tesla

$351.09

-15.39 (-4.20%)

GM

General Motors

VLKAY

Volkswagen

$34.57

0.46 (1.35%)

F

Ford

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

  • 02

    Oct

  • 03

    Oct

  • 26

    Oct

SBRA

Sabra Health Care

$22.21

0.03 (0.14%)

09:23
09/25/17
09/25
09:23
09/25/17
09:23
Initiation
Sabra Health Care initiated  »

Sabra Health Care…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Sep

09:20
09/25/17
09/25
09:20
09/25/17
09:20
General news
Treasury Action: supply is on tap this week »

Treasury Action: supply…

SPX

S&P 500

, VIX

Volatility Index S&P 500 Options

09:18
09/25/17
09/25
09:18
09/25/17
09:18
Options
Overnight activity included 98 trades in SPX and 33 trades in VIX »

98 trades were executed…

SPX

S&P 500

VIX

Volatility Index S&P 500 Options

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NTNX

Nutanix

$24.50

1.04 (4.43%)

09:17
09/25/17
09/25
09:17
09/25/17
09:17
Recommendations
Nutanix analyst commentary  »

Nutanix price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AMZN

Amazon.com

$955.10

-9.55 (-0.99%)

09:16
09/25/17
09/25
09:16
09/25/17
09:16
Hot Stocks
Amazon signs first-look production deal with Casey Affleck's Sea Change Media »

Amazon Studios has closed…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    Oct

  • 22

    Oct

09:15
09/25/17
09/25
09:15
09/25/17
09:15
General news
The Hurricane Lift for U.S. Producer Sentiment Has Begun: »

The Hurricane Lift for…

TUWOY

Tullow Oil

$1.19

0.08 (7.21%)

09:14
09/25/17
09/25
09:14
09/25/17
09:14
Upgrade
Tullow Oil rating change  »

Tullow Oil upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AAPL

Apple

$151.89

-1.5 (-0.98%)

, S

Sprint

09:14
09/25/17
09/25
09:14
09/25/17
09:14
Recommendations
Apple, Sprint, STMicroelectronics analyst commentary  »

Initial Apple iPhone 8…

AAPL

Apple

$151.89

-1.5 (-0.98%)

S

Sprint

STM

STMicroelectronics

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    Oct

  • 22

    Oct

  • 16

    May

FINL

Finish Line

$9.73

0.51 (5.53%)

09:14
09/25/17
09/25
09:14
09/25/17
09:14
Recommendations
Finish Line analyst commentary  »

Finish Line takeout…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CCL

Carnival

$64.33

-0.12 (-0.19%)

09:13
09/25/17
09/25
09:13
09/25/17
09:13
Recommendations
Carnival analyst commentary  »

Carnival estimates raised…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

  • 26

    Sep

YUM

Yum! Brands

09:13
09/25/17
09/25
09:13
09/25/17
09:13
Conference/Events
Yum! Brands management to meet with JPMorgan »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Sep

  • 28

    Sep

AMZN

Amazon.com

$955.10

-9.55 (-0.99%)

09:12
09/25/17
09/25
09:12
09/25/17
09:12
Hot Stocks
Amazon signs multi-year deal with Amy Sherman-Palladino, Daniel Palladino »

Amazon announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    Oct

  • 22

    Oct

MSM

MSC Industrial

09:11
09/25/17
09/25
09:11
09/25/17
09:11
Initiation
MSC Industrial initiated  »

MSC Industrial initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 31

    Oct

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.